Trial Profile
Phase Ib trial of brostallicin in combination with bevacizumab or irinotecan in patients with advanced solid tumours
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Brostallicin (Primary) ; Bevacizumab; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions; Pharmacogenomic
- 01 Nov 2007 New trial record.